Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NDV-HXP-S-KP.2 Mucosal Vaccine vs mRNA Vaccine in Previously Vaccinated Adults
NCT07215520Phase 2Active, not recruiting
- Sponsor
- CastleVax
- Start
- Nov 2025
- Primary completion
- Sep 2026
- Modality
- Viral Vectors, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of NDV-HXP-S-KP.2 in coronavirus disease 2019 (COVID-19), sponsored by CastleVax. Started Nov 2025; status: active, not recruiting.
02
Drugs
NDV-HXP-S-KP.2
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT07215520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07215520.